News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,736 Results
Type
Article (41911)
Company Profile (299)
Press Release (660526)
Section
Business (208581)
Career Advice (2214)
Deals (36020)
Drug Delivery (91)
Drug Development (81622)
Employer Resources (171)
FDA (16497)
Job Trends (15247)
News (351664)
Policy (33111)
Tag
Academia (2681)
Alliances (50815)
Alzheimer's disease (1240)
Approvals (16412)
Artificial intelligence (131)
Bankruptcy (357)
Best Places to Work (11871)
Biotechnology (209)
Breast cancer (118)
Cancer (1007)
Cardiovascular disease (85)
Career advice (1847)
Cell therapy (217)
Clinical research (64571)
Collaboration (356)
Compensation (183)
COVID-19 (2623)
C-suite (87)
Data (981)
Diabetes (148)
Diagnostics (6347)
Earnings (85549)
Employer resources (149)
Events (111903)
Executive appointments (276)
FDA (16978)
Funding (317)
Gene therapy (164)
GLP-1 (588)
Government (4435)
Healthcare (19313)
Infectious disease (2706)
Inflammatory bowel disease (105)
Interviews (369)
IPO (16506)
Job creations (3712)
Job search strategy (1569)
Layoffs (421)
Legal (7991)
Lung cancer (162)
Manufacturing (166)
Medical device (13723)
Medtech (13728)
Mergers & acquisitions (19557)
Metabolic disorders (392)
Neuroscience (1501)
NextGen Class of 2024 (6810)
Non-profit (4611)
Northern California (1347)
Obesity (231)
Opinion (186)
Patents (98)
People (57538)
Phase I (20064)
Phase II (28427)
Phase III (21225)
Pipeline (329)
Postmarket research (2588)
Preclinical (8580)
Radiopharmaceuticals (239)
Rare diseases (199)
Real estate (6093)
Regulatory (21924)
Research institute (2439)
Resumes & cover letters (374)
Southern California (1197)
Startups (3665)
United States (12711)
Vaccines (574)
Weight loss (171)
Date
Today (129)
Last 7 days (969)
Last 30 days (3374)
Last 365 days (36094)
2024 (32018)
2023 (40799)
2022 (52029)
2021 (56711)
2020 (55483)
2019 (48321)
2018 (36461)
2017 (33053)
2016 (32601)
2015 (38659)
2014 (32284)
2013 (27263)
2012 (29506)
2011 (30126)
2010 (28051)
Location
Africa (760)
Arizona (189)
Asia (38329)
Australia (6288)
California (3036)
Canada (1224)
China (236)
Colorado (134)
Connecticut (139)
Europe (83846)
Florida (420)
Georgia (118)
Illinois (346)
Indiana (194)
Kansas (97)
Maryland (556)
Massachusetts (2445)
Michigan (164)
Minnesota (268)
New Jersey (895)
New York (899)
North Carolina (708)
Northern California (1347)
Ohio (134)
Pennsylvania (796)
South America (1157)
Southern California (1197)
Texas (420)
Utah (88)
Washington State (343)
702,736 Results for "ablative solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Ablative Solutions, Inc. Announces Primary Endpoint Met in the TARGET BP I Pivotal Trial of the Peregrine System™ Kit for Patients with Uncontrolled Hypertension
Ablative Solutions, Inc., today announced that the TARGET BP I Pivotal Trial evaluating alcohol-mediated renal denervation with the Peregrine System ™ Kit met its primary endpoint, showing a statistically significant difference in 24-hour Ambulatory Blood Pressure between treatment and sham procedure at 3 months.
December 19, 2023
·
2 min read
Press Releases
ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors
October 4, 2024
·
2 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
Press Releases
SCIEX and Bioinformatics Solutions Inc. Further Collaboration for Proteomic Advancement
October 23, 2024
·
3 min read
Business
Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates
Biocytogen Pharmaceuticals and ABL Bio Inc. today announced a collaboration to develop new bispecific antibody-drug conjugates (bsADCs).
March 25, 2024
·
4 min read
Business
UL Solutions Inc. Reports Strong First Quarter 2024 Results
UL Solutions Inc. (“UL Solutions” or the “Company”) (NYSE: ULS), a global safety science leader in independent third-party testing, inspection and certification services and related software and advisory offerings, today reported results for the first quarter ended March 31, 2024.
May 20, 2024
·
30 min read
Genetown
Ablative Solutions, Inc. Announces Enrollment Completion of TARGET BP I Study for Patients with Uncontrolled Hypertension
Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of patient enrollment in the TARGET BP I Pivotal Study evaluating alcohol-mediated renal denervation with the Peregrine System.
April 12, 2023
·
2 min read
Press Releases
Peytant Solutions, Inc. Granted FDA De Novo for AMStent® Tracheobronchial Covered Stent System
October 22, 2024
·
2 min read
Press Releases
Bracco Diagnostics Inc. Obtains Hallmark Achievement of One Million Injections with its MRI agent VUEWAY® (gadopiclenol) solution for injection
November 12, 2024
·
7 min read
Business
Stryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions
October 2, 2024
·
1 min read
1 of 70,274
Next
